CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, announced today the pricing of its upsized initial public offering of 10,

The Company has granted the underwriters an option, exercisable for 45 days from the closing of this Offering, to purchase up to an additional 210,000 Ordinary Shares at the Offering Price, representing 15% of the Ordinary Shares sold in the Offering (the “Over-allotment”).

KinderCare Learning Companies, Inc. (“KinderCare”), the nation’s largest private provider of high-quality early childhood education by center capacity

XCHG Limited (“XCharge” or the “Company”) (NASDAQ: XCH), a global leader in integrated EV charging solutions, today announced that the underwriter of the Company’

Click Holdings Limited (“ CLIK ” or the “ Company ”), a Hong Kong-based human resources solutions provider primarily focusing on talent sourcing and the provision of temporary and permanent personnel to customers including accounting and professional firms,

(Reuters) -Upstream Bio, which is developing treatments for some respiratory disorders, said on Thursday it had raised $255 million in its initial public offering in the United States. The drug developer joins a swath of biotech companies rushing towards a stock market listing as a long-awaited policy easing cycle begins.

The gross proceeds to Upstream from the initial public offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $255.0 million. Registration statements relating to the shares sold in the initial public offering have been filed with the Securities and Exchange Commission and became effective on October 10,